Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹6,414 Cr
Revenue (TTM)
₹4,791 Cr
Net Profit (TTM)
₹90 Cr
ROE
5.1 %
ROCE
7 %
P/E Ratio
71.2
P/B Ratio
3.7
Industry P/E
--
EV/EBITDA
32.3
Div. Yield
0 %
Debt to Equity
0.2
Book Value
₹393.6
EPS
₹20.7
Face value
10
Shares outstanding
43,507,707
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Entero Health
| 2.7 | 11.5 | 16.6 | 38.7 | -- | -- | -- |
|
BSE Healthcare
| -5.3 | 2.6 | 6.3 | 20.0 | 23.4 | 23.5 | 9.8 |
|
BSE Small Cap
| -6.0 | 7.4 | 16.0 | 7.4 | 24.9 | 37.8 | 16.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Entero Health
|
1,463.1 | 6,413.9 | 4,790.9 | 97.2 | 2.6 | 5.4 | 71.2 | 3.7 |
| 1,185.1 | 9,749.0 | 1,006.9 | 160.4 | 20.4 | 12.6 | 61.4 | 7.4 | |
| 512.6 | 12,500.7 | 4,460.0 | 479.1 | 16.4 | 14.4 | 26.1 | 3.5 | |
| 23.9 | 10.5 | 29.1 | -0.3 | 7.6 | -258.7 | -- | 2.1 | |
| 43.0 | 54.7 | 26.4 | -3.4 | -14.1 | -2.8 | -- | 0.4 | |
| 43.9 | 27.6 | 0.2 | 0.2 | -120.5 | 2.5 | 117.3 | 2.9 | |
| 5,289.5 | 8,750.4 | 1,159.5 | 236.6 | 28.3 | 43.8 | 37 | 14.3 | |
| 21.8 | 11.9 | 0.7 | -0.3 | -39.3 | -55.6 | -- | 24.1 | |
| 2.5 | 9.8 | 7.4 | -0.7 | -5.1 | -15.2 | -- | 2.5 | |
| 11.4 | 128.5 | 33.4 | 1.9 | 7.0 | 3.7 | 68 | 1.3 |
IPO: Entero Healthcare Solutions
4 min read•By Satyajit Sen
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, healthcare product manufacturers, and healthcare clinics in India. The company is involved in the distribution of... medical devices, over the counter medical products, nutraceuticals, and vaccines. It also offers nebulizers, digital thermometers, blood pressure monitors, and adult diapers. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India. Read more
Incorporated
2018
Chairman
Sujesh Vasudevan
Managing Director
Prabhat Agrawal
Headquarters
Faridabad, Haryana
Website
Looking for more details about Entero Healthcare Solutions Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Entero Healthcare Solutions Ltd stood at ₹ 2,653 Cr as on 31-Dec-24
The share price of Entero Healthcare Solutions Ltd is ₹1,463.10 (NSE) and ₹1,462.35 (BSE) as of 19-May-2025 13:34 IST. Entero Healthcare Solutions Ltd has given a return of 38.75% in the last 1 years.
Entero Healthcare Solutions Ltd has a market capitalisation of ₹ 6,414 Cr as on 19-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Entero Healthcare Solutions Ltd is 3.75 times as on 19-May-2025, a 75% premium to its peers’ median range of 2.14 times.
The P/E ratio of Entero Healthcare Solutions Ltd is 71.19 times as on 19-May-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Entero Healthcare Solutions Ltd and enter the required number of quantities and click on buy to purchase the shares of Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, healthcare product manufacturers, and healthcare clinics in India. The company is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. It also offers nebulizers, digital thermometers, blood pressure monitors, and adult diapers. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.
The promoters of Entero Healthcare Solutions Ltd are Orbimed Asia III Mauritius Limited and Prabhat Agrawal. They collectively own 47.27 per cent of the total equity. The chairman of the company is Sujesh Vasudevan
There is no promoter pledging in Entero Healthcare Solutions Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
132
|
|
|
53
|
|
|
28
|
|
|
12
|
|
|
10
|
|
|
8
|
|
|
12,274
|
|
|
9,199
|
|
|
8,615
|
| Entero Healthcare Solutions Ltd | Ratios |
|---|---|
|
Return on equity(%)
|
5.43
|
|
Operating margin(%)
|
2.55
|
|
Net Margin(%)
|
2.01
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Entero Healthcare Solutions Ltd was ₹90 Cr.
₹-16.40
(
